Jaffre et al_Circulation-2019.pdf
Fabrice Jaffré
Clint Miller
Amy Roberts
Anne Schanzer
Todd Evans
Andreas Hahn
Maria I. Kontaridis
10.25376/hra.9624845.v1
https://hra.figshare.com/articles/journal_contribution/Jaffre_et_al_Circulation-2019_pdf/9624845
Here we used iPSC-derived cardiomyocytes and CRISPR-Cas9 to delineate the molecular mechanisms underlying hypertrophic cardiomyopathy in Noonan syndrome individuals with a mutation in RAF1. <br>
2019-08-14 18:24:35
cardiomyocytes
ips
Noonan syndrome
CRSIPR/Cas9
RNA sequencing
Signaling pathways
Molecular Biology
Cardiology